Cancer of Colon Clinical Trial
Official title:
Significance of Immunohistochemical Expression of Fascin-1 in Colorectal Carcinoma
Colorectal carcinoma is a major health problem. As a malignant tumor, the malignant potential of colorectal carcinoma is based mainly on its ability to metastasis to different sites. Fascin-1 is an actin binding protein which is involved in reconstruction of intracellular actin network, the latter enforces the neoplastic cell to invade surrounding structures.
colorectal carcinoma is an aggressive malignant tumor. It has high incidence of cancer-related morbidity and mortality. the malignant potential of a given neoplasm is based mainly on its ability to invade the surrounding vasculature and reach to distant sites, the latter is called metastasis. in order to metastasize to distant sites, the neoplastic cells must re-arrange the intracellular actin filaments into well formed intracellular assembly which enable the neoplastic cells to reach to distant sites. Fascin-1 is an actin binding protein, it is involved in reconstruction of actin assembly. fortunately, Fascin-1 could be blocked by newly developed medications, blocking of Fascin-1 may limit the metastasis of colorectal carcinoma. in current study the investigators detect Fascin-1 in colorectal carcinoma by immunohistochemical approach, then they correlated different levels of Fascin-1 expression to tumor clinical and pathological criteria as patients' ages, sexes, tumor stages, nodal metastasis, vascular and per-ineural invasions. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05982184 -
Effect of Music Prehabilitation on Preoperative Anxiety Before Surgery
|
N/A | |
| Completed |
NCT04160650 -
Educational Nursing Intervention Among Patients With Colorectal Cancer During Chemotherapy
|
N/A | |
| Recruiting |
NCT05179824 -
Tempus Priority Study: A Pan-tumor Observational Study
|
||
| Completed |
NCT04716010 -
Developing and Evaluating Product Messaging
|
N/A | |
| Terminated |
NCT03524820 -
Cetuximab Therapy for Third Line Rechallenge in Metastatic Colorectal Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT02458664 -
BASE HSP110 : A New Therapeutic Target and a New Marker for Prognosis of Type MSI Colorectal Cancer
|
N/A | |
| Completed |
NCT03246438 -
Choice Architecture and Colorectal Cancer Screening Outreach
|
N/A | |
| Recruiting |
NCT04028479 -
The Registry of Oncology Outcomes Associated With Testing and Treatment
|
||
| Not yet recruiting |
NCT03910283 -
Leveraging Mindsets to Improve Health & Wellbeing in Patients With Cancer
|
N/A | |
| Completed |
NCT03928678 -
Implementation of Enhanced Recovery After Surgery Program (ERAS) in Colorectal Cancer Surgery, a Randomized Controlled Trial
|
N/A | |
| Completed |
NCT03546569 -
Tumor Cells, Tumor DNA and Immunological Response in Colonic Stent Placement
|
||
| Recruiting |
NCT03896958 -
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)
|
||
| Not yet recruiting |
NCT06035731 -
Evaluation of the Medical Service by Socio-aesthetics in Oncology
|
N/A | |
| Completed |
NCT04971304 -
Comparative Effectiveness Analysis of Granulocyte Colony Stimulating Factor Originator Products Versus Biosimilars
|
||
| Completed |
NCT05030090 -
Integrative Nutrition Care Plan for the Patient With Liver and Colorectal Cancer
|
N/A | |
| Not yet recruiting |
NCT04773626 -
Tumor Deposits in Cancer Colon
|
||
| Recruiting |
NCT05887531 -
Abdominopelvic Cancer Prehabilitation
|
N/A | |
| Withdrawn |
NCT04274790 -
Impact of 5-Fluorouracil (5-FU) on Cancer Cells From Liver Metastases of Colon Cancer
|
||
| Completed |
NCT03416777 -
Meat-based Versus Pesco-vegetarian Diet and Colorectal Cancer
|
N/A | |
| Completed |
NCT03210129 -
Motivational Interviewing to Increase Physical Activity Behaviour in Cancer Patients
|
N/A |